Showing results (171-180 of 289) with videos related to
Sort By:
Pageof 29
Plos One|August 10, 2017
Proliferative capacity exhibited by human liver-resident CD49a+CD25+ NK cellsGlòria Martrus, Tobias Kautz, Sebastian Lunemann, et al.Plos One|July 21, 2018
Tissue-resident NK cells differ in their expression profile of the nutrient transporters Glut1, CD98 and CD71Wilhelm Salzberger, Gloria Martrus, Kai Bachmann, et al.Journal of Immunological Methods|March 28, 2022
A simple, robust flow cytometry-based whole blood assay for investigating sex differential interferon alpha production by plasmacytoid dendritic cellsOliver Sampson, Nicholas Lim, Jemima White, et al.Hepatology (Baltimore, Md.)|January 30, 2018
Carcinoembryonic antigen-related cell adhesion molecule 1 controls IL-2-dependent regulatory T-cell induction in immune-mediated hepatitis in miceAndrea Kristina Horst, Claudia Wegscheid, Christoph Schaefers, et al.Plos One|October 12, 2017
Saporin-conjugated tetramers identify efficacious anti-HIV CD8+ T-cell specificitiesEllen M Leitman, Christine D Palmer, Søren Buus, et al.Cell Research|February 1, 2012
Preferential CTL targeting of Gag is associated with relative viral control in long-term surviving HIV-1 infected former plasma donors from ChinaMingming Jia, Kunxue Hong, Jianping Chen, et al.AIDS (London, England)|June 17, 2004
HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversityMathias Lichterfeld, Xu G Yu, Daniel Cohen, et al.Journal of Virology|May 12, 2007
Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I allelesHendrik Streeck, Mathias Lichterfeld, Galit Alter, et al.Cell Reports|August 31, 2017
Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOVAnne Rechtien, Laura Richert, Hadrien Lorenzo, et al.The Journal of Infectious Diseases|August 31, 2006
Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infectionHendrik Streeck, Heiko Jessen, Galit Alter, et al.Pageof 29